Same thing that happens to people in New York City who can't afford fast-acting insulin or EpiPen? Your two examples are telling given the current state of pharma business.

I hate this meme; and that's what is is nowadays, a meme. There are generics for both EpiPen and fast acting insulin. You can walk into a Walmart and buy R for $25/bottle [1]; it didn't even require a prescription, the last I bought it. Sure, it's not as good as Apidra and the like, but it does work; it just requires a more controlled diet. The generic EpiPen is just over $100 for a 2-pack.

I get it, there's stories every now and then of some person that died because they couldn't afford their insulin (for $275/bottle). And every time I stare at the story wondering why that person decided to kill themself for reason.

I get it that newer insulins should be cheaper, that they're way over priced. But it's disingenuous to pretend there aren't options for people that can't afford them.

[1] https://www.walmart.com/ip/novolin-r-relion/129783484

That should probably read:

Your two examples are telling given the current state American healthcare system. I don't think its a problem in Europe.